ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CEL Celadon Pharmaceuticals Plc

32.50
-0.90 (-2.69%)
Last Updated: 08:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Celadon Pharmaceuticals Plc LSE:CEL London Ordinary Share GB00BDQYGP38 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  -0.90 -2.69% 32.50 12,742 08:00:00
Bid Price Offer Price High Price Low Price Open Price
30.00 35.00 32.50 32.50 32.50
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Investment Advice 149k -7.14M -0.1078 -3.01 22.12M
Last Trade Time Trade Type Trade Size Trade Price Currency
08:56:12 O 3,058 32.4999 GBX

Celadon Pharmaceuticals (CEL) Latest News

Celadon Pharmaceuticals (CEL) Discussions and Chat

Celadon Pharmaceuticals Forums and Chat

Date Time Title Posts
02/10/202409:48Celadon Pharmaceuticals Plc88
19/3/202316:34Caparo Energy23
10/10/200918:30Celsis - Sales and Profits grow1,036
06/6/200816:22Chris Evans - Biotech Guru1,401
04/7/200709:03Celsis - Bios that make money23

Add a New Thread

Celadon Pharmaceuticals (CEL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
07:56:1332.503,058993.85O
07:25:4930.757,5002,306.25O
07:12:0931.801,534487.81O
07:11:3431.803711.77O
07:07:4231.80613194.93O

Celadon Pharmaceuticals (CEL) Top Chat Posts

Top Posts
Posted at 23/8/2024 16:10 by citys2874
would love CEL and URU to finish top number 1 and number 2 on leaderboard today
Posted at 23/8/2024 16:09 by citys2874
CEL up 70 percent nice
Posted at 23/8/2024 15:41 by citys2874
check out URU could well be a tripple bagger, worth buying a few today, fab day so far for Both CEL and URU
Posted at 13/8/2024 12:12 by firestorm911
F911 is proudly reducing the target price from 1p to 0.000911p.

Good shs to short.

Enjoy !!

Regards,
F911
RMC
Posted at 12/8/2024 09:31 by jaknife
Celadon informs the market that:

1. It hasn't received all of cash from the May placing (three months after!),

2. It hasn't received the cash from the loan announced in May, and

3. It only has £48k of cash left before it's lights off time
Posted at 03/7/2024 10:50 by jaknife
talk2dubya,

"Well the facilities alone are worth 60m. Nice update"

I'm afraid that whomever told you that was taking advantage of your naivety.

The accounts are quite clear:



CEL has invested less than £3m into its "facilities", which are loss-making.

JakNife
Posted at 03/7/2024 10:35 by talk2dubya
I don’t think I have ever held a share as poor as this, in terms of shareholder engagement and newsflow.
Posted at 22/5/2024 21:02 by czar
Its funny investors keep committing money at above the market price when the vast majority have to raise at huge discounts. Somebody can see a big return here, could they be right?
Posted at 10/5/2024 07:59 by czar
These new investors want in to CEL and are happy to pay the offer price, that speaks volumes for what they know about this business.
Posted at 14/3/2023 15:42 by oakridge
Some thoughts on CEL and HELD (from the HELD thread) below.

(Don't forget CEL possibly need a cash injection so don't get greedy on the spike!)


Oakridge14 Mar '23 - 15:20 - 480 of 481 Edit
0 1 0

News out at CEL.

Great news for the cannabis space.

What we can say is that CEL, or, those involved in the work around this RNS = a leaky ship! Including that big volume spike / buy a few weeks ago. Naughty!


Oakridge14 Mar '23 - 15:40 - 481 of 481 Edit
0 0 0


It's important to watch the reaction at CEL, and particularly the rocket that has been put under the companies share price over recent days.

The home office has now extended their license so that they can enter into commercial (non research) agreements to sell a high THC content product to third parties and are the first UK based pharmaceutical facility / cultivators in the UK to do this.

They say:

"Within the UK, patients prescribed medicinal cannabis are reliant on imported product, often facing lengthy delays and high costs, and by becoming a UK-based producer, Celadon is in a prime position to alleviate the issues currently faced by patients."

Well, it's going to be interesting to see what price-point CEL can come in at and maintain. They've already announced that expansion into their second growing room had to delayed this year by spiralling costs we have all grown so familiar with.

Their facilities are, I think, only around 10% of HELD's entire license. I'll check on that.

So, whilst they may be first over the line and should be congratulated, the scale of their operations, at present, is a fraction of what HELD have been granted in Greece. CEL are also operating from a country with considerably higher costs.

Current mkt cap: £265M

HELD: c.£11M.

HELD still have work to do, but should, all being well, be rubber stamped and selling product at around the end of Q2.

AIMO ADYOR
Celadon Pharmaceuticals share price data is direct from the London Stock Exchange

Your Recent History

Delayed Upgrade Clock